Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 57 days ( 0 % )
Last Price $1.73 0 %
High/ Low $1.73 - $1.73 0%
Chg 7 Days N/A $1.73 $1.73
Chg 30 Days N/A $1.73 $1.73
Chg 12 mos 136.63 % $0.729 $1.73
Trend - 3 mos -6.45 % Width: 35.80 %
Trend - 12 mos 53.94 % Width: 13,978.19 %
Pred. range - 3 mos $1.48 - $2.01 -13.98 % - 16.81 %
Pred. range - 12 mos $0.0976 - $13.74 -94.34 % - 696.46 %
Short MA avg 3 mos Buy Apr 08, 2024 - 61 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Mar 11, 2024 - 80 days
Long MA avg 12 mos Sell Mar 28, 2024 - 67 days
Short/Long MA avg 12 mos Sell Apr 11, 2024 - 58 days
Pivot Short Buy Apr 05, 2024 - 62 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals. Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targe... EIGR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT